Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Mei Geng"'
Publikováno v:
HemaSphere, Vol 7, p e89168b4 (2023)
Externí odkaz:
https://doaj.org/article/214e4450405c4919b7c2794dee89d9b8
Autor:
Li-Jun Peng, Yue-Bo Zhou, Mei Geng, Ekaterina Bourova-Flin, Florent Chuffart, Wei-Na Zhang, Tao Wang, Meng-Qing Gao, Meng-Ping Xi, Zhong-Yi Cheng, Jiao-Jiao Zhang, Yuan-Fang Liu, Bing Chen, Saadi Khochbin, Jin Wang, Sophie Rousseaux, Jian-Qing Mi
Publikováno v:
BMC Genomics, Vol 23, Iss 1, Pp 1-14 (2022)
Abstract Background T cell acute lymphoblastic leukemia (T-ALL) defines a group of hematological malignancies with heterogeneous aggressiveness and highly variable outcome, making therapeutic decisions a challenging task. We tried to discover new pre
Externí odkaz:
https://doaj.org/article/39260e69d4ec429bb1b256535fcf0d99
Autor:
Man Ou, Mei Geng, Xiangle Fang, Wenfan Shao, Fenghong Bai, Shipeng Wan, Caichao Ye, Yuping Wu, Yuhui Chen
Publikováno v:
Advanced Science, Vol 10, Iss 15, Pp n/a-n/a (2023)
Abstract Direct photoelectrochemical 2‐electron water oxidation to renewable H2O2 production on an anode increases the value of solar water splitting. BiVO4 has a theoretical thermodynamic activity trend toward highly selective water oxidation H2O2
Externí odkaz:
https://doaj.org/article/c47a1e17fa6d4521bddd65a6c443c29f
Autor:
Tong-bing Wang, Mei Geng, Hua Jin, Ai-guo Tang, Hao Sun, Liu-zheng Zhou, Bin-hai Chen, Gang Shen, Qiang Sun
Publikováno v:
Cell Death and Disease, Vol 12, Iss 8, Pp 1-11 (2021)
Abstract Renal cell carcinoma (RCC) cells have increased lipogenesis and cholesterol synthesis. Sterol regulatory element-binding protein-1 (SREBP1) is cleaved by site 1 protease (S1P) to release the transcriptionally active amino-terminal domain. PF
Externí odkaz:
https://doaj.org/article/91a402a328784f37bc4909b49438acc7
Publikováno v:
Frontiers in Energy Research, Vol 10 (2022)
Externí odkaz:
https://doaj.org/article/519a332d6606444d93b78d0961e1e567
Autor:
Yu, Yue, Lu, Juan, Sun, Le, Lyu, Xinkai, Chang, Xin-yue, Mi, Xiao, Hu, Mei-geng, Wu, Chongming *, Chen, Xi *
Publikováno v:
In Biomedicine & Pharmacotherapy January 2021 133
Autor:
Zhu, Nai-Liang, Xu, Xu-Dong, Hu, Mei-Geng, Sun, Zhong-Hao, Wu, Tong-Yu, Yuan, Jing-Quan, Wu, Hai-Feng, Tian, Yu, Li, Peng-Fei, Yang, Jun-Shan, Ma, Guo-Xu
Publikováno v:
In Phytochemistry Letters December 2017 22:113-116
Publikováno v:
International Journal of Dermatology and Venereology. 5:191-198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23cf045d3d92103eb5be1a408396f242
https://doi.org/10.1097/jd9.0000000000000275
https://doi.org/10.1097/jd9.0000000000000275
Publikováno v:
Acta Haematologica.
Introduction: Despite the promising clinical trial data regarding programmed death 1 (PD-1) inhibitors in relapsed/ refractory classical Hodgkin lymphoma (R/R cHL), there remains a paucity of studies describing the outcomes of patients in a real-worl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45f7425a7e397528d984bd31365ee5a3
https://doi.org/10.1159/000530323
https://doi.org/10.1159/000530323
Autor:
Yan Wu, Wei Lai, Jing Li, Qing Sun, Chen Yuan, Hong Fang, Hongzhong Jin, Xian Jiang, You-Kun Lin, Xiao-Jing Kang, Song-Mei Geng, Jun Gu, Li He, Hang Li, Qiang Ju, Juan Tao, Zhong-Shuai Wang, Hongfu Xie, Yu-Zhen Li, Shan-Shan Li, Yan Yan, Gang Wang, Baoxi Wang, Xing-Hua Gao
Publikováno v:
International Journal of Dermatology and Venereology. 5:1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5818bc20d28e1daccfca7567a8c6a18d
https://doi.org/10.1097/jd9.0000000000000204
https://doi.org/10.1097/jd9.0000000000000204